Cannabis in Medicine: A Primer for Health Care Professionals
On the first day of a National Medical Cannabis Unity Conference, an accredited cannabinoid education program will offer a CRE to healthcare professionals.
By Americans for Safe Access | January 25, 2013
This course provides an expert overview of the clinical use of cannabis, providing health care professionals with up-to-date clinical information on the therapeutic potential of cannabis and the endocannabinoid system.
Physicians who attend will receive 2.75 AMA PRA Category 1 credits.
The program is jointly sponsored by the Canadian Consortium for the Investigation of Cannabinoids and the University of California-San Francisco, in collaboration with the Society of Cannabis Clinicians and is supported by an unrestricted educational grant from the Americans for Safe Access Foundation.
The objective of this CME is to present a balanced and expert overview on the clinical use of cannabinoids to an engaged audience of healthcare professionals.
The lecture series will focus on the clinical and practical therapeutic potential of cannabinoids and the endocannabinoid system.
At the end of the session, participants will be able to:
1. Describe the components and functions of the endocannabinoid system
2. Understand the effects of cannabis smoking on the lung
3. Summarize the indications for existing cannabinoid therapeutic agents
4. Outline the issues in cannabinoid drug trials, including safety and efficacy issues
5. Explore and discuss attitudes towards cannabinoids in clinical use
To register online directly please visit the University of California, San Francisco website.
For more information, including course agenda, faculty, and registration, go to: www.ccic.net/USACME.
Short URL: http://medicalmarijuana411.com/mmj411_v3/?p=13803